Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Stomach Neoplasms 1Prostatic Neoplasms 1Oropharyngeal Neoplasms 1Neoplastic Cells, Circulating 1Hypoxia 1Colorectal Neoplasms 1Circulating Tumor DNA 1

Interventions

Cisplatin 6Radiotherapy 5Surveys and Questionnaires 4Paclitaxel 3Surgical Procedures, Operative 2Physical Examination 2Gemcitabine 2Drug Therapy 2Docetaxel 2Cetuximab 2Blood Specimen Collection 2pembrolizumab 1nimotuzumab 1fluoromisonidazole 1fludarabine 1durvalumab 1Rubidium-82 1Ropivacaine 1Ritonavir 1Nivolumab 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Liquid Biopsy 1Lidocaine 1Interviews as Topic 1Indinavir 1Immunotherapy 1Fluorouracil 1Fluorodeoxyglucose F18 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Oropharyngeal Neoplasms × Circulating Tumor DNA × Clear all
NCT04920344 2023-11-03

Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy

Rutgers, The State University of New Jersey

Phase 2 Unknown
15 enrolled
Head & Neck

Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡